Impedimed

ImpediMed is a medical technology company specializing in bioimpedance spectroscopy (BIS) to provide non-invasive solutions for the early detection, monitoring, and management of chronic diseases such as lymphedema, heart failure, and protein calorie malnutrition. They generate revenue through the sale of their proprietary devices and related software, as well as through service agreements and licensing deals. Founded in 1999, ImpediMed has a significant history of innovation in the healthcare sector, including the development of the first FDA-cleared BIS device for lymphedema assessment.

Recent Posts by Impedimed

1-20 of 21